Core Viewpoint - Ningbo Fuda has announced the termination of its major asset restructuring plan, which was aimed at acquiring a significant stake in Jingxin Materials, due to the inability to reach a final agreement on the transaction terms [2][5][6]. Group 1: Termination of Restructuring - The termination of the major asset restructuring was agreed upon after thorough discussions and negotiations among all parties involved, leading to the signing of a termination agreement for the investment cooperation intention [3][5]. - The restructuring process began on January 17, when Ningbo Fuda intended to acquire at least 45% of Jingxin Materials through cash transactions, with the goal of making Jingxin a subsidiary [6][7]. Group 2: Impact on Business - Ningbo Fuda stated that the termination of the restructuring will not have a significant adverse impact on its current operations, financial status, or strategic development, as the transaction was still in the planning stage and no substantial agreements had been reached [7][8]. - The company reported a significant decline in revenue for 2024, with a projected revenue of 1.701 billion yuan, down 46.31% year-on-year, and a net profit of 210 million yuan, down 8.83% [8].

过会逾两年后，同宇新材料（广东）股份有限公司（以下简称"同宇新材"）IPO终于进入下一阶段。4月14日，同宇新材创业板IPO提交注册，公司成功闯 进"注册关"。然而，在闯关IPO的关键时期，公司业绩表现却并不给力，报告期内公司净利接连出现下滑。与此同时，报告期内，同宇新材五类拳头产品平 均单价也在接连走低。针对相关问题，同宇新材方面于4月15日接受了北京商报记者的采访。 4月14日，同宇新材创业板IPO提交注册，公司冲击上市进入最后一关。 深交所官网显示，同宇新材创业板IPO于2022年6月28日获得受理，2022年7月24日进入问询阶段，并于2023年4月7日上会获得通过。不难看出，在本次提交 注册前，公司IPO已排队近三年时间。 招股书显示，同宇新材主营业务系电子树脂的研发、生产和销售，主要应用于覆铜板生产。公司产品主要包括MDI改性环氧树脂、DOPO改性环氧树脂、高 溴环氧树脂、BPA型酚醛环氧树脂、含磷酚醛树脂固化剂等五个系列。需要指出的是，在冲击上市的关键时期，同宇新材业绩却出现接连下滑。财务数据显 示，2022—2024年，公司实现营业收入约为11.93亿元、8.86亿元、9.52亿元；对应实现归 ...